The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
PD-L1 expression in patients with metastatic gastric cancer in South Korea.
 
Hyo Song Kim
No Relationships to Disclose
 
Ting Wu
No Relationships to Disclose
 
Hyunki Kim
No Relationships to Disclose
 
Hyun Cheol Chung
Consulting or Advisory Role - Bristol-Myers Squibb; Celltrion; Lilly; Merck Sharp & Dohme; Quintiles; Taiho Pharmaceutical
Speakers' Bureau - Lilly; Merck Serono
Research Funding - GlaxoSmithKline; Lilly; Merck Sharp & Dohme
 
Jaffer A. Ajani
Honoraria - Bayer; Five Prime Therapeutics; Genentech; Lilly/ImClone; Novartis; Roche/Genentech; Taiho Pharmaceutical
Research Funding - Amgen; Bristol-Myers Squibb; Delta-Fly Pharma; Gilead Sciences; Lilly/ImClone; MedImmune; Merck; Novartis; Roche/Genentech; Taiho Pharmaceutical; Takeda
Patents, Royalties, Other Intellectual Property - I have research funding from: Genentech, Roche, BMS, Taiho, MedImmune, Merck, Amgen, Lilly
Travel, Accommodations, Expenses - Bayer; Five Prime Therapeutics; Novartis
 
Geoffrey Yuyat Ku
Consulting or Advisory Role - AstraZeneca/MedImmune; Bayer
Research Funding - Arog (Inst); Bristol-Myers Squibb (Inst); MedImmune (Inst); Merck (Inst)
Travel, Accommodations, Expenses - AstraZeneca/MedImmune
 
David Paul Kelsen
No Relationships to Disclose
 
Xingshu Zhu
Employment - Merck
 
Mary J. Savage
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Minori Koshiji
Employment - Merck
 
Sun Young Rha
No Relationships to Disclose